article

1. Clinical and System-Level Factors Driving Donor Lung Utilization Decisions: A Qualitative Study..  Annals of the American Thoracic Society.  22:1155-1164. 2025
2. The landscape of referrals for lung transplantation in pulmonary arterial hypertension: A report from the Pulmonary Hypertension Association Registry..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  2025
3. Frailty in lung transplant recipients is associated with anemia and telomere dysfunction but independent of epigenetic age..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  25:1916-1925. 2025
4. Persistent and progressive acute lung allograft dysfunction is linked to cell compositional and transcriptional changes in small airways..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  44:1482-1492. 2025
5. Postoperative Lung Transplant Considerations in the Older Recipient..  Chest.  168:435-448. 2025
6. A randomized trial of open lung protective ventilation compared to conventional mechanical ventilation in deceased organ donors..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  44:1251-1259. 2025
7. Cytomegalovirus-associated CD57 + KLRG1 + CD8 + TEMRA T cells are associated with reduced risk of CMV viremia in kidney transplantation and chronic allograft dysfunction in lung transplantation..  Human immunology.  86:-. 2025
8. Evaluation of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Recipients..  Transplant infectious disease : an official journal of the Transplantation Society.  27:-. 2024
9. Disturbed sleep after lung transplantation is associated with worse patient-reported outcomes and chronic lung allograft dysfunction..  JHLT open.  -. 2024
10. Differences in Health Care and Palliative Care Use at the End of Life: A Comparison Study Among Lung Cancer, COPD, and Idiopathic Pulmonary Fibrosis..  Chest.  166:1487-1496. 2024
11. Improvements in Patient-Reported Functioning after Lung Transplant is Associated with Improved Quality of Life and Survival..  medRxiv : the preprint server for health sciences.  2024
12. Small airway brush gene expression predicts chronic lung allograft dysfunction and mortality..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  43:1820-1832. 2024
13. Body mass index and mortality following primary graft dysfunction: A Lung Transplant Outcomes Group study..  JHLT open.  -. 2024
14. Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  43:1074-1086. 2024
15. Immune aging: biological mechanisms, clinical symptoms, and management in lung transplant recipients..  Frontiers in transplantation.  -. 2024
16. Disturbed sleep after lung transplantation is associated with worse patient-reported outcomes and chronic lung allograft dysfunction..  medRxiv : the preprint server for health sciences.  2024
17. Disturbed sleep after lung transplantation is associated with worse patient-reported outcomes and chronic lung allograft dysfunction..  medRxiv : the preprint server for health sciences.  2024
18. MICB.  American journal of respiratory and critical care medicine.  209:70-82. 2024
19. The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation..  American journal of respiratory and critical care medicine.  209:91-100. 2024
20. Development and validation of primary graft dysfunction predictive algorithm for lung transplant candidates..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  43:633-641. 2023
21. National Prevalence of Social Isolation and Loneliness in Adults with Chronic Obstructive Pulmonary Disease..  Annals of the American Thoracic Society.  20:1709-1717. 2023
22. Provider beliefs and practices regarding the management of obesity in lung transplant recipients..  JHLT open.  2023
23. CCR5 drives NK cell-associated airway damage in pulmonary ischemia-reperfusion injury..  JCI insight.  8. 2023
24. Accuracy and Reproducibility of Automated Measurement of Body Composition: A Lung Transplant Body Composition Cohort Study..  Annals of the American Thoracic Society.  20:1363-1366. 2023
25. Short airway telomeres are associated with primary graft dysfunction and chronic lung allograft dysfunction..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  42:1700-1709. 2023
26. European Respiratory Society statement on frailty in adults with chronic lung disease..  The European respiratory journal.  62. 2023
27. Decreased Lymphocytic Bronchitis Severity in the Era of Azithromycin Prophylaxis..  Transplantation direct.  9:-. 2023
28. Biofire pneumonia panel in lung donors: faster detection but limited pathogens..  Transplant infectious disease : an official journal of the Transplantation Society.  25:-. 2023
29. The Association Between Frailty and Chronic Lung Allograft Dysfunction After Lung Transplantation..  Transplantation.  107:2255-2261. 2023
30. Body Mass Index and Cause-Specific Mortality after Lung Transplantation in the United States..  Annals of the American Thoracic Society.  20:825-833. 2023
31. Rehabilitation for People with Respiratory Disease and Frailty: An Official American Thoracic Society Workshop Report..  Annals of the American Thoracic Society.  20:767-780. 2023
32. What is Frailty?.  American journal of respiratory and critical care medicine.  207:P5-P6. 2023
33. Mismatch identified in symptom burden profiles in lung transplantation..  Heart & lung : the journal of critical care.  165-172. 2023
34. Development of the Lung Transplant Frailty Scale (LT-FS)..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  42:892-904. 2023
35. Subphenotypes of frailty in lung transplant candidates..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  23:531-539. 2023
36. Design and implementation of a digital health home spirometry intervention for remote monitoring of lung transplant function..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  42:828-837. 2023
37. Association of Frailty With Health-Related Quality of Life in Liver Transplant Recipients..  JAMA surgery.  158:130-138. 2023
38. The Lung Allocation Score Remains Inequitable for Patients with Pulmonary Arterial Hypertension, Even after the 2015 Revision..  American journal of respiratory and critical care medicine.  207:300-311. 2023
39. Frailty and genetic risk predict fracture after lung transplantation..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  23:214-222. 2023
40. Echocardiographic estimation of pulmonary vascular resistance in advanced lung disease..  Pulmonary circulation.  13:-. 2023
41. NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes..  JCI insight.  7. 2022
42. Sarcopenia Predicts Outcomes After Lung Transplantation in Older Lung Transplant Candidates..  Annals of thoracic surgery short reports.  1:174-178. 2022
43. Intercostal Nerve Cryoanalgesia Versus Thoracic Epidural Analgesia in Lung Transplantation: A Retrospective Single-Center Study..  Pain and therapy.  12:201-211. 2022
44. Contemporary trends in PGD incidence, outcomes, and therapies..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  41:1839-1849. 2022
45. Quality of Life Outcomes and Associated Symptoms Reported by Lung Transplant Recipients Amidst COVID-19 Pandemic: Applying a Novel Assessment Tool..  Transplantation proceedings.  54:2680-2687. 2022
46. The Intersection of Aging and Lung Transplantation: its Impact on Transplant Evaluation, Outcomes, and Clinical Care..  Current transplantation reports.  9:149-159. 2022
47. Current Beliefs and Practices Regarding the Management of Obesity in Patients with Progressive Interstitial Lung Disease..  Annals of the American Thoracic Society.  19:1602-5. 2022
48. Depressive symptoms in lung transplant recipients: trajectory and association with mortality and allograft dysfunction..  Thorax.  77:891-899. 2022
49. Inflammation on bronchoalveolar lavage cytology is associated with decreased chronic lung allograft dysfunction-free survival..  Clinical transplantation.  36:-. 2022
50. ADAM8 signaling drives neutrophil migration and ARDS severity..  JCI insight.  7. 2022
51. Lung transplant recipients with idiopathic pulmonary fibrosis have impaired alloreactive immune responses..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  41:641-653. 2021
52. Lung Allograft Epithelium DNA Methylation Age Is Associated With Graft Chronologic Age and Primary Graft Dysfunction..  Frontiers in immunology.  -. 2021
53. Construct and Predictive Validity of Sarcopenia in Lung Transplant Candidates..  Annals of the American Thoracic Society.  18:1464-1474. 2021
54. Lung Transplantation for Patients With COVID-19..  Chest.  161:169-178. 2021
55. Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry..  Annals of the American Thoracic Society.  18:613-622. 2021
56. The association of post-operative delirium with patient-reported outcomes and mortality after lung transplantation..  Clinical transplantation.  35:-. 2021
57. Lung transplantation from swimming pool drowning victims: A case series..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  21:2273-2278. 2021
58. Rapid molecular detection of airway pathogens in lung transplant recipients..  Transplant infectious disease : an official journal of the Transplantation Society.  23:-. 2021
59. Mobile health technology to improve emergent frailty after lung transplantation..  Clinical transplantation.  35:-. 2021
60. Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury..  The Journal of clinical investigation.  131. 2021
61. Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  40:351-358. 2021
62. Frailty and aging-associated syndromes in lung transplant candidates and recipients..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  21:2018-2024. 2020
63. Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  21:2145-2160. 2020
64. Complement activation on endothelium initiates antibody-mediated acute lung injury..  The Journal of clinical investigation.  130:5909-5923. 2020
65. Chronic lung allograft dysfunction small airways reveal a lymphocytic inflammation gene signature..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  21:362-371. 2020
66. Primary graft dysfunction attenuates improvements in health-related quality of life after lung transplantation, but not disability or depression..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  21:815-824. 2020
67. Pseudomonas.  Cell reports. Medicine.  1. 2020
68. Skeletal muscle adiposity and outcomes in candidates for lung transplantation: a lung transplant body composition cohort study..  Thorax.  75:801-804. 2020
69. Ingenol mebutate 0·015% gel is safe for short-term treatment of actinic keratoses on the face in solid organ transplant recipients..  The British journal of dermatology.  183:575-577. 2020
70. Risk Factors and Outcomes of Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation..  Seminars in thoracic and cardiovascular surgery.  32:772-785. 2020
71. Frailty after lung transplantation is associated with impaired health-related quality of life and mortality..  Thorax.  75:669-678. 2020
72. Pathobiology of frailty in lung disease..  Translational research : the journal of laboratory and clinical medicine.  1-22. 2020
73. Improvements in frailty contribute to substantial improvements in quality of life after lung transplantation in patients with cystic fibrosis..  Pediatric pulmonology.  55:1406-1413. 2020
74. Improved survival after lung transplantation for adults requiring preoperative invasive mechanical ventilation: A national cohort study..  The Journal of thoracic and cardiovascular surgery.  160:1385-1395.e6. 2020
75. Mitochondrial DNA Stimulates TLR9-Dependent Neutrophil Extracellular Trap Formation in Primary Graft Dysfunction..  American journal of respiratory cell and molecular biology.  62:364-372. 2020
76. Tacrolimus trough monitoring guided by mass spectrometry without accounting for assay differences is associated with acute kidney injury in lung transplant recipients..  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.  76:2019-2027. 2019
77. Dectin-1 genetic deficiency predicts chronic lung allograft dysfunction and death..  JCI insight.  4. 2019
78. Frailty and the Burden of Concurrent and Incident Disability in Patients With Cirrhosis: A Prospective Cohort Study..  Hepatology communications.  4:126-133. 2019
79. Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines..  Transplant international : official journal of the European Society for Organ Transplantation.  32:1268-1276. 2019
80. Discharge frailty following lung transplantation..  Clinical transplantation.  33:-. 2019
81. Transplantation in the Face of Donor-Specific Antibodies: A Pathway to Become Better..  Annals of the American Thoracic Society.  16:1114-1115. 2019
82. Adipose tissue quantification and primary graft dysfunction after lung transplantation: The Lung Transplant Body Composition study..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  38:1246-1256. 2019
83. A nonlinear relationship between visceral adipose tissue and frailty in adult lung transplant candidates..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  19:3155-3161. 2019
84. Management and clinical outcomes after lung transplantation in patients with pre-transplant Mycobacterium abscessus infection: A single center experience..  Transplant infectious disease : an official journal of the Transplantation Society.  21:-. 2019
85. Development and Preliminary Validation of the Lung Transplant Quality of Life (LT-QOL) Survey..  American journal of respiratory and critical care medicine.  199:1008-1019. 2019
86. Gene signatures common to allograft rejection are associated with lymphocytic bronchitis..  Clinical transplantation.  33:-. 2019
87. Frailty trajectories in adult lung transplantation: A cohort study..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  38:699-707. 2019
88. NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients..  Transplantation.  103:493-501. 2019
89. Report from the American Society of Transplantation on frailty in solid organ transplantation..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  19:984-994. 2018
90. National Heart, Lung, and Blood Institute and American Association for Thoracic Surgery Workshop Report: Identifying collaborative clinical research priorities in lung transplantation..  The Journal of thoracic and cardiovascular surgery.  156:2355-2365. 2018
91. The 2018 ISHLT/APM/AST/ICCAC/STSW Recommendations for the Psychosocial Evaluation of Adult Cardiothoracic Transplant Candidates and Candidates for Long-term Mechanical Circulatory Support..  Psychosomatics.  59:415-440. 2018
92. Genotypes associated with tacrolimus pharmacokinetics impact clinical outcomes in lung transplant recipients..  Clinical transplantation.  32:-. 2018
93. A mobile health technology enabled home-based intervention to treat frailty in adult lung transplant candidates: A pilot study..  Clinical transplantation.  32:-. 2018
94. Low dose posaconazole delayed release tablets for fungal prophylaxis in lung transplant recipients..  Clinical transplantation.  32:-. 2018
95. Suppressed calcineurin-dependent gene expression identifies lung allograft recipients at increased risk of infection..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  18:2043-2049. 2018
96. Frailty phenotypes and mortality after lung transplantation: A prospective cohort study..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  18:1995-2004. 2018
97. The 2018 ISHLT/APM/AST/ICCAC/STSW recommendations for the psychosocial evaluation of adult cardiothoracic transplant candidates and candidates for long-term mechanical circulatory support..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  37:803-823. 2018
98. Defining Success in Lung Transplantation: From Survival to Quality of Life..  Seminars in respiratory and critical care medicine.  39:255-268. 2018
99. Elevated donor plasminogen activator inhibitor-1 levels and the risk of primary graft dysfunction..  Clinical transplantation.  32:-. 2018
100. Improvement in patient-reported outcomes after lung transplantation is not impacted by the use of extracorporeal membrane oxygenation as a bridge to transplantation..  The Journal of thoracic and cardiovascular surgery.  156:440-448.e2. 2018
101. Moving Pulmonary Rehabilitation Into the Home: A CLINICAL REVIEW..  Journal of cardiopulmonary rehabilitation and prevention.  38:8-16. 2018
102. Pulmonary Hypertension and Primary Graft Dysfunction in Lung Transplant Recipients: We Still Have a Long Way to Go..  Annals of the American Thoracic Society.  14:1504-1505. 2017
103. Frailty and maximal exercise capacity in adult lung transplant candidates..  Respiratory medicine.  70-76. 2017
104. Refining Low Physical Activity Measurement Improves Frailty Assessment in Advanced Lung Disease and Survivors of Critical Illness..  Annals of the American Thoracic Society.  14:1270-1279. 2017
105. Report of the International Society for Heart and Lung Transplantation Working Group on Primary Lung Graft Dysfunction, part II: Epidemiology, risk factors, and outcomes-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  36:1104-1113. 2017
106. HLA Mismatching Favoring Host-Versus-Graft NK Cell Activity Via KIR3DL1 Is Associated With Improved Outcomes Following Lung Transplantation..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  17:2192-2199. 2017
107. Short lung transplant donor telomere length is associated with decreased CLAD-free survival..  Thorax.  72:1052-1054. 2017
108. Effect of Lung Transplantation on Health-Related Quality of Life in the Era of the Lung Allocation Score: A U.S. Prospective Cohort Study..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  17:1334-1345. 2017
109. Donor-Reactive Regulatory T Cell Frequency Increases During Acute Cellular Rejection of Lung Allografts..  Transplantation.  100:2090-8. 2016
110. Frailty in Pulmonary and Critical Care Medicine..  Annals of the American Thoracic Society.  13:1394-404. 2016
111. Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013..  Journal of the American Academy of Dermatology.  75:106-12. 2016
112. Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation..  American journal of respiratory and critical care medicine.  192:1325-34. 2015
113. Prolonged Barium-Impaction Ileus in Two Lung Transplant Recipients With Systemic Sclerosis: Case Report..  Transplantation proceedings.  47:2965-7. 2015
114. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  16:262-70. 2015
115. Lung transplantation for hypersensitivity pneumonitis..  Chest.  147:1558-1565. 2015
116. Clinical outcomes of lung transplant recipients with telomerase mutations..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  34:1318-24. 2015
117. Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey..  Transplant infectious disease : an official journal of the Transplantation Society.  17:14-20. 2015
118. Defining novel health-related quality of life domains in lung transplantation: a qualitative analysis..  Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation.  24:1521-33. 2014
119. Body composition and mortality after adult lung transplantation in the United States..  American journal of respiratory and critical care medicine.  190:1012-21. 2014
120. Belatacept for Maintenance Immunosuppression in Lung Transplantation..  Journal of investigative medicine high impact case reports.  2:-. 2014
121. The feasibility of lung transplantation in HIV-seropositive patients..  Annals of the American Thoracic Society.  11:882-9. 2014
122. Lung Transplantation for Scleroderma-related Lung Disease..  Current respiratory care reports.  3:79-87. 2014
123. A randomized trial of the effects of nebulized albuterol on pulmonary edema in brain-dead organ donors..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  14:621-8. 2014
124. Bronchoalveolar lavage cell immunophenotyping facilitates diagnosis of lung allograft rejection..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  14:831-40. 2014
125. Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients..  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.  58:997-1002. 2013
126. Development and validation of a lung transplant-specific disability questionnaire..  Thorax.  69:437-42. 2013
127. Quality of life in lung transplantation..  Seminars in respiratory and critical care medicine.  34:421-30. 2013
128. Outcomes in systemic sclerosis-related lung disease after lung transplantation..  Transplantation.  95:975-80. 2013
129. A thematic analysis of quality of life in lung transplant: the existing evidence and implications for future directions..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  13:839-850. 2013
130. Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis..  Transplant infectious disease : an official journal of the Transplantation Society.  15:E70-4. 2013
131. Rhinovirus and other respiratory viruses exert different effects on lung allograft function that are not mediated through acute rejection..  Clinical transplantation.  27:E64-71. 2012
132. Defining patient-reported outcomes in chronic obstructive pulmonary disease: the patient-centered experience..  The Medical clinics of North America.  96:767-87. 2012
133. Both pulmonary and extra-pulmonary factors predict the development of disability in chronic obstructive pulmonary disease..  Respiration; international review of thoracic diseases.  85:375-83. 2012
134. Relationship of obesity with respiratory symptoms and decreased functional capacity in adults without established COPD..  Primary care respiratory journal : journal of the General Practice Airways Group.  21:194-201. 2012
135. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  31:694-9. 2012
136. Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis..  Transplant infectious disease : an official journal of the Transplantation Society.  14:248-58. 2012
137. The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients..  Journal of the American Academy of Dermatology.  67:829-35. 2012
138. Use of sublingual tacrolimus in lung transplant recipients..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  31:127-32. 2011
139. An analysis of potential risk factors for early complications from fiberoptic bronchoscopy in lung transplant recipients..  Transplant international : official journal of the European Society for Organ Transplantation.  25:172-8. 2011
140. Survival following lung transplantation for silicosis and other occupational lung diseases..  Occupational medicine (Oxford, England).  62:134-7. 2011
141. The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation..  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.  11:2197-204. 2011
142. Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function..  Journal of cardiopulmonary rehabilitation and prevention.  31:111-9. 2011
143. Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole..  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].  36:1752-5. 2010
144. The impact of a "low-intensity" versus "high-intensity" medical intensive care unit on patient outcomes in critically ill veterans..  Journal of intensive care medicine.  25:233-9. 2010
145. Supratherapeutic anticoagulation from low-molecular-weight heparin in lung transplant recipients..  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.  29:1009-13. 2010
146. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus..  The Journal of thoracic and cardiovascular surgery.  125:246-53. 2003
147. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival..  Oncogene.  20:3528-32. 2001